Aethlon Medical Inc (NASDAQ:AEMD) shares, rose in value on Wednesday, June 18, with the stock price down by -1.69% to the previous day’s close as strong demand from buyers drove the stock to $1.74.
Actively observing the price movement in the last trading, the stock closed the session at $1.77, falling within a range of $1.6576 and $1.8346. The value of beta (5-year monthly) was 1.879. Referring to stock’s 52-week performance, its high was $8.44, and the low was $1.67. On the whole, AEMD has fluctuated by -47.58% over the past month.
With the market capitalization of Aethlon Medical Inc currently standing at about $3.50 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AEMD’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of AEMD currently trading nearly -31.47% and -38.45% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 21.30, while the 7-day volatility ratio is showing 5.75% which for the 30-day chart, stands at 5.16%. Furthermore, Aethlon Medical Inc (AEMD)’s beta value is 1.88, and its average true range (ATR) is 0.26.
A comparison of Aethlon Medical Inc (AEMD) with its peers suggests the former has fared considerably weaker in the market. AEMD showed an intraday change of -1.69% in last session, and over the past year, it shrunk by -68.61%%.
Data on historical trading for Aethlon Medical Inc (NASDAQ:AEMD) indicates that the trading volumes over the past 10 days have averaged 0.1 and over the past 3 months, they’ve averaged 26.72K. According to company’s latest data on outstanding shares, there are 2.01 million shares outstanding.
Nearly 6.09% of Aethlon Medical Inc’s shares belong to company insiders and institutional investors own 21.03% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11831.0 shares as on 2025-05-30, resulting in a short ratio of 0.59. According to the data, the short interest in Aethlon Medical Inc (AEMD) stood at 7.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 12760.0. The stock has fallen by -74.71% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AEMD stock heading into the next quarter.
